Daniel Camardo

Daniel Camardo is an Adjunct Professor in the Healthcare Program at the Kellogg School of Management (Northwestern University), where he teaches Pharmaceutical Strategy. He currently serves as President of Immedica North America, a subsidiary of Immedica Pharma AB, and holds roles in biotechnology leadership, including former positions as acting CEO of Athersys, Inc., and Executive Vice President at Horizon Therapeutics.

Education: B.A. in Economics with a minor in Mathematics from the University of Rochester; MBA from the Kellogg School of Management.

Research interests focus on drug commercialization, regulatory frameworks, and navigating multi-stakeholder networks in the pharmaceutical industry. He has extensive experience launching therapies in Oncology, Neurology, Immunology, and Rare Diseases.

Award recognition information is not detailed in the provided texts. He advises no listed students and has no published articles recorded here. He serves on the Board of Directors for CommunityHealth, Chicago’s volunteer-based healthcare provider for underserved populations.